Lilly's obesity pill largely maintains weight lost on injectable GLP-1s

Fierce Biotech·Dec 18

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

A pill for obesity treatment has shown to largely maintain weight lost on injectable GLP-1s. The development of this pill is part of a broader trend of new weight loss drugs, including a recently approved pill version of Novo Nordisk's Wegovy. Eli Lilly is also seeking FDA approval for its own GLP-1 weight loss pill, which has shown promise in trials.

Full coverage

GLP-1 Weight-Loss Pills: What You Need to Know

Yale Medicine·Apr 10

Where the blockbuster weight loss drug market stands today — and what’s coming next

CNBC·Nov 2

Eli Lilly’s Experimental Pill Could Help You Ditch GLP-1 Obesity Shots, Trial Finds

Gizmodo·Dec 18

Lilly seeks FDA approval for its GLP-1 weight loss pill

TechTarget·Dec 18

View original report at Fierce Biotech ↗

Fetching the latest headlines…

Lilly's obesity pill largely maintains weight lost on injectable GLP-1s

Full coverage

GLP-1 Weight-Loss Pills: What You Need to Know

Where the blockbuster weight loss drug market stands today — and what’s coming next

FDA approves pill version of Novo Nordisk’s Wegovy, possibly widening access

The biggest potential drug launches of 2026

FDA approves Wegovy weight loss pill from Novo Nordisk

Next gen GLP-1 drugs orforglipron and retatrutide: Your questions answered

Eli Lilly’s Experimental Pill Could Help You Ditch GLP-1 Obesity Shots, Trial Finds

Lilly seeks FDA approval for its GLP-1 weight loss pill